Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651 1657 1699
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17797252 | ANGIOGENESIS DEVICE | Non-Final OA | TOHOKU UNIVERSITY |
| 17797241 | ANGIOGENESIS DEVICE | Non-Final OA | TOHOKU UNIVERSITY |
| 19089115 | Microbial Conversion of CO2 and Other C1 Substrates to Vegan Nutrients, Fertilizers, Biostimulants, and Systems for Accelerated Soil Carbon Sequestration | Non-Final OA | Kiverdi, Inc. |
| 19089124 | Microbial Conversion of CO2 and Other C1 Substrates to Vegan Nutrients, Fertilizers, Biostimulants, and Systems for Accelerated Soil Carbon Sequestration | Non-Final OA | Kiverdi, Inc. |
| 17866522 | Microbial Conversion of CO2 and Other C1 Substrates to Vegan Nutrients, Fertilizers, Biostimulants, and Systems for Accelerated Soil Carbon Sequestration | Final Rejection | Kiverdi, Inc. |
| 18549792 | METHOD FOR PRODUCING HYPOIMMUNOGENIC RETINAL PIGMENT EPITHELIAL CELLS | Non-Final OA | RIKEN |
| 17915067 | RADIATION SENSITIVITY DIAGNOSIS METHOD | Final Rejection | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| 18153476 | USE OF CYANOBACTERIA AS A COVER CROP | Final Rejection | BIODEL AG INC. |
| 17796436 | METHOD OF TREATING PANCREATIC CANCER | Final Rejection | CEDARS-SINAI MEDICAL CENTER |
| 18067732 | Decontamination of Environmental Water Sources Using Living Engineered Biofilm Materials | Non-Final OA | ShanghaiTech University |
| 17921553 | STEM CELL DRUG FOR TREATING DIABETES | Non-Final OA | SOOCHOW UNIVERSITY |
| 17912394 | USE OF MITOCHONDRIAL EXTRACT TO TREAT AND/OR PREVENT KIDNEY INJURY-RELATED DISEASE | Non-Final OA | Taiwan Mitochondrion Applied Technology Co., Ltd. |
| 17365027 | ECONOMIC SUGAR STREAM, PROCESSES AND SYSTEMS OF PRODUCING SAME | Final Rejection | POET Research, Inc. |
| 18536601 | FEED SUPPLEMENT BOLUS WITH ACTIVE YEAST | Non-Final OA | TECHMIX, LLC |
| 18504080 | PLATELET DERIVATIVES FOR TREATING COAGULOPATHY | Non-Final OA | Cellphire, Inc. |
| 18015209 | TARGETED DRUG DELIVERY TO SITES OF INTRAVASCULAR OCCLUSION | Final Rejection | Children's Medical Center Corporation |
| 18252254 | THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS | Non-Final OA | SHANGHAI SEME CELL TECHNOLOGY CO., LTD. |
| 18040466 | Therapeutic Use of Cell-free Fat Extract Solution for Pulmonary Diseases | Final Rejection | SHANGHAI SEME CELL TECHNOLOGY CO., LTD. |
| 18031793 | USE OF MICROORGANISMS AND CALCIUM FOR IMPROVED PLANT HELATH AND/OR RESILIENCE AGAINST PLANT PATHOGENS | Final Rejection | Valibiotics GmbH |
| 17927714 | BIOMARKER COMPOSITION FOR PREDICTING PROGNOSIS OF BRAIN DISEASE CAUSED BY MICROPLASTIC EXPOSURE AND METHOD FOR PREDICTING PROGNOSIS USING SAME | Non-Final OA | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES |
| 17835208 | METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS | Non-Final OA | Celcuity Inc. |
| 17402535 | METHODS FOR USING ANTIMICROBIAL COMPOSITIONS | Non-Final OA | Next Science IP Holdings Pty Ltd |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy